TR-1 NOTIFICATION OF MAJOR INTEREST IN SHARES
1. Identity of the issuer or the underlying issuer of FINSBURY
existing shares to which voting rights are attached: WORLDWIDE
PHARMACEUTICAL
TRUST PLC
2. Reason for the notification (please tick the appropriate box or
boxes):
An acquisition or disposal of voting rights
An acquisition or disposal of financial instruments which may result X
in the acquisition of shares already issued to which voting rights
are attached
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification EAST RIDING OF
obligation: YORKSHIRE COUNCIL
4. Full name of shareholder(s) (if different from 3.): -
5. Date of the transaction and date on which the 30 MARCH 2007
threshold is crossed or reached:
6. Date on which issuer notified: 2 APRIL 2007
7. Threshold(s) that is/are crossed or reached: 27%
8. Notified details: 27.30%
A: Voting rights attached to shares
Class/type Situation previous to Resulting situation after the triggering
of shares the Triggering transaction
if possible transaction
using the
ISIN CODE Number Number of Number of Number of voting % of voting
of Voting shares rights rights
Shares Rights
Direct Direct Indirect Direct Indirect
ORDINARY 1,800,000 1,800,000 1,800,000 N/A 3.45% N/A
SHARES
GB0003385308
B: Financial Instruments
Resulting situation after the triggering transaction
Type of Expiration Exercise/ Number of voting rights that % of
financial date Conversion may be acquired if the voting
instrument Period/ Date instrument is exercised/ rights
converted.
WARRANTS 31 JULY EACH YEAR ON 31 2,950,000 27.30%
(NON 2009 JULY BETWEEN 2005 (NON VOTING) (NON
VOTING) AND 2009 INC. VOTING)
Total (A+B)
Number of voting rights % of voting rights
1,800,000 3.45
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable
N/A
Proxy Voting:
10. Name of the proxy holder: N/A
11. Number of voting rights proxy holder will cease to hold: N/A
12. Date on which proxy holder will cease to hold voting rights: N/A
13. Additional VOTING RIGHTS (BOX A) BASED ON 52,142,781 ORDINARY SHARES (TO
information: WHICH VOTING RIGHTS ARE ATTRIBUTABLE) IN ISSUE.
NON VOTING RIGHTS (BOX B) BASED ON 10,804,056 WARRANTS IN
ISSUE.
14. Contact name: MARK POPE
15. Contact 020 3 008 4913
telephone number:
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.